Asensus Surgical Inc
F:2TX

Watchlist Manager
Asensus Surgical Inc Logo
Asensus Surgical Inc
F:2TX
Watchlist
Price: 0.3 EUR -1.64% Market Closed
Market Cap: €81.8m

Asensus Surgical Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Asensus Surgical Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Asensus Surgical Inc
F:2TX
Research & Development
-$35m
CAGR 3-Years
-27%
CAGR 5-Years
-9%
CAGR 10-Years
-9%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$2.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Edwards Lifesciences Corp
NYSE:EW
Research & Development
-$1.1B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Stryker Corp
NYSE:SYK
Research & Development
-$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.9B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
No Stocks Found

Asensus Surgical Inc
Glance View

Market Cap
81.8m EUR
Industry
Health Care

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 183 full-time employees. The firm is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The firm is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.

2TX Intrinsic Value
Not Available

See Also

What is Asensus Surgical Inc's Research & Development?
Research & Development
-35m USD

Based on the financial report for Mar 31, 2024, Asensus Surgical Inc's Research & Development amounts to -35m USD.

What is Asensus Surgical Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-9%

Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for Asensus Surgical Inc have been -27% over the past three years , -9% over the past five years , and -9% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett